Does Maternal Depression or Stress Affect Fetal Growth?
BACKGROUND AND PURPOSE:
Intrauterine fetal growth restriction (FGR or IUGR), defined as weight below the 10th percentile, has been associated with excessive maternal stress
Most studies are based on birth weight, and therefore cannot fully assess timing of various exposures in addition to confounders
Grobman et al. (Journal of Ultrasound in Medicine, 2017) sought to determine whether women reporting greater perceived stress or depression symptoms at start of or during pregnancy would demonstrate altered longitudinal fetal growth
NICHD Fetal Growth Study multicenter prospective (2009 – 2013)
Women screened at 8 weeks and 13 weeks 6 days gestation for stress/depression status and underwent serial sonographic examinations
Definition of high risk
Cohen Perceived Stress Scale (PSS): Score ≥ 15
Edinburgh Postpartum Depression Survey (EPDS): Score of ≥ 10 (13 used for sensitivity analysis)
Fetal weight growth curves and individual biometric parameters were created using serial sonographic data
Interaction between race/ethnicity and stress/depression scores were assessed
Multicenter longitudinal study of 2334 women
89% and 90% of women completed PSS and EPDS, respectively, at least once in all trimesters
Despite participant’s reported PSS or EPDS score, longitudinal growth curves and fetal weight were similar
Race/ethnicity did not modify biometric parameters
Quantified depressive symptoms and greater perceived stress are not associated with alterations in fetal growth throughout all three trimesters
Authors recommend further research to determine whether combination of stress and/or depression with environmental factors may alter fetal growth
This paper complements the Wing et al. study that likewise did not find an association between perceived maternal stress and neonatal growth measurements (summarized in ‘Related ObG Topics’ below)
Please login to access ObGFirst and the T2 US Atlas
Media - Internet
Computer System Requirements
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly provided by
NOT ENOUGH CME HOURS
It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan